Here's Why We Think Tradeweb Markets (NASDAQ:TW) Is Well Worth Watching
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away.
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Tradeweb Markets (NASDAQ:TW). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing.
If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That means EPS growth is considered a real positive by most successful long-term investors. Shareholders will be happy to know that Tradeweb Markets' EPS has grown 28% each year, compound, over three years. As a result, we can understand why the stock trades on a high multiple of trailing twelve month earnings.
One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. Our analysis has highlighted that Tradeweb Markets' revenue from operations did not account for all of their revenue in the previous 12 months, so our analysis of its margins might not accurately reflect the underlying business. EBIT margins for Tradeweb Markets remained fairly unchanged over the last year, however the company should be pleased to report its revenue growth for the period of 29% to US$1.7b. That's encouraging news for the company!
The chart below shows how the company's bottom and top lines have progressed over time. To see the actual numbers, click on the chart.
View our latest analysis for Tradeweb Markets
Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for Tradeweb Markets.
Since Tradeweb Markets has a market capitalisation of US$34b, we wouldn't expect insiders to hold a large percentage of shares. But we are reassured by the fact they have invested in the company. To be specific, they have US$32m worth of shares. That shows significant buy-in, and may indicate conviction in the business strategy. While their ownership only accounts for 0.09%, this is still a considerable amount at stake to encourage the business to maintain a strategy that will deliver value to shareholders.
For growth investors, Tradeweb Markets' raw rate of earnings growth is a beacon in the night. This EPS growth rate is something the company should be proud of, and so it's no surprise that insiders are holding on to a considerable chunk of shares. Fast growth and confident insiders should be enough to warrant further research, so it would seem that it's a good stock to follow. Of course, profit growth is one thing but it's even better if Tradeweb Markets is receiving high returns on equity, since that should imply it can keep growing without much need for capital. Click on this link to see how it is faring against the average in its industry.
While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in the US with promising growth potential and insider confidence.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
41 minutes ago
- Associated Press
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 8, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) "[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit
Yahoo
an hour ago
- Yahoo
UK will handle US security concerns over new Chinese embassy plan, says Kyle
Security issues over plans for a Chinese embassy near London's financial centres will be 'taken care of assiduously', a minister said after the White House warned Downing Street against allowing the project to go ahead. Technology Secretary Peter Kyle indicated the UK would offer a 'fulsome response' to any concerns raised by allies amid suggestions that US opposition could undermine transatlantic trade negotiations. Mr Kyle sought to reassure the public that the Government deals with similar 'infrastructure issues' relating to embassies 'all the time'. 'These issues will be taken care of assiduously in the planning process,' he told Sky News's Sunday Morning With Trevor Phillips programme. He added: 'These are the issues that we talk about as two countries all the time… we're in the Five Eyes agreement, America and Britain share intelligence… If people raise security issues even though it relates to planning, then I'm sure we will have a fulsome response for them. 'But look, the key thing is these are issues which are quite routinised in the way that we deal with the security of our country.' A senior US official had told the Sunday Times: 'The United States is deeply concerned about providing China with potential access to the sensitive communications of one of our closest allies.' The matter is believed to have been discussed during US-UK trade talks, with diplomats saying the Trump administration would have reservations about intelligence sharing with the UK if the building went ahead. More than a thousand demonstrators gathered earlier this year for a rally against the proposed Chinese 'super-embassy' because of concerns about its potential proximity to Canary Wharf and the City of London. The redevelopment plans at the former site of the Royal Mint were 'called in' last year, which means the Government will make the final decision following a report from the Planning Inspectorate. The plan was initially refused by Tower Hamlets Council in 2022.
Yahoo
2 hours ago
- Yahoo
Microsoft Tops $3.5 Trillion Market Cap, Beats Nvidia
Microsoft (NASDAQ:MSFT) hit a new high as its market capitalization topped $3.5 trillion, edging out Nvidia (NASDAQ:NVDA) and solidifying its lead among the Magnificent Seven. Warning! GuruFocus has detected 5 Warning Sign with MSFT. Shares of Microsoft climbed to a record $467.68 on Thursday, up 0.8%, before adding another 0.6% on Friday to push its market cap past $3.5 trillion. Nvidia wasnt far behind, trading up 1.3% on Friday with a market cap of $3.47 trillion, while Apple (NASDAQ:AAPL) also breached the $3 trillion mark with a 1% gain to reach $3.02 trillion. Microsofts stock has outpaced the broader Nasdaq (IND), rising 11% year-to-date compared to the indexs modest sub-1% gain. The software giant has been powered by robust growth in its cloud unit, Azure, where revenue jumped 28% year-over-year in Q3 FY25, and by its deepening partnership with OpenAI, which has driven strong demand for AI-powered services. Bernstein Societe Generale Group raised its price target on Microsoft to $540 from $520, citing significant upside potential as Azure continues to scale and AI integration expands across enterprise offerings. Bernstein analysts retained their Outperform rating, noting that Microsofts diversified revenue streamsfrom Office 365 subscriptions to LinkedIn and gamingprovide a hedge against macro uncertainties. Nvidias gains have been fueled by surging demand for its H100 and H200 GPUs, which dominate the AI data-center market, helping it close the gap with Microsoft. Apples performance, meanwhile, reflects resilient iPhone sales and growing services revenue, which has climbed 17% year-over-year to $21 billion in Q2 FY25. Why It Matters: Microsofts $3.5 trillion valuation underscores the escalating AI and cloud war between the tech titans, where gains in enterprise adoption and AI partnerships can translate directly into market-cap milestones. The battle for supremacy now hinges on execution in generative AI, data-center infrastructure and enterprise software integrations. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data